Clinical Trials
15 trialsNCT05063565 2026-06-01
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT06624644 2026-04-22
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Phase 2/3 Recruiting
NCT06974110 2026-04-15
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
NCT05488626 2026-02-05
ARTIA-Lung
Varian, a Siemens Healthineers Company
Phase NA Withdrawn
NCT06163053 2026-01-14
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
Bristol-Myers Squibb
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04638751 2024-04-05
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Unknown
NCT02609386 2024-01-30
INSPIRE
Brooklyn ImmunoTherapeutics, LLC
Phase 2 Completed
NCT02054520 2023-04-18
Immunotherapy Study for Patients With Stage IV Melanoma
Lumos Pharma
Phase 2 Terminated
NCT02035358 2022-04-06
Immunotherapy Study for Metastatic Renal Cell Cancer
Lumos Pharma
Phase 1 Completed
NCT04690686 2022-03-08
Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).
Immunicom Inc
Phase 2 Unknown
NCT05137912 2022-02-07
Neoadjuvant Immunotherapy in Advanced NSCLC
Power Life Sciences Inc.
Unknown
NCT01675765 2020-09-30
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Aduro Biotech, Inc.
Phase 1 Completed
NCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed
NCT00089856 2008-11-05
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Cell Genesys
Phase 3 Terminated